Your browser is no longer supported. Please, upgrade your browser.
Settings
RATE Bankrate, Inc. daily Stock Chart
RATE [NYSE]
Bankrate, Inc.
Index- P/E- EPS (ttm)-0.28 Insider Own4.20% Shs Outstand92.53M Perf Week4.00%
Market Cap1.08B Forward P/E16.91 EPS next Y0.69 Insider Trans0.00% Shs Float46.16M Perf Month4.00%
Income-24.40M PEG- EPS next Q0.19 Inst Own48.60% Short Float1.42% Perf Quarter10.90%
Sales412.90M P/S2.62 EPS this Y133.20% Inst Trans1.30% Short Ratio1.70 Perf Half Y52.74%
Book/sh7.85 P/B1.49 EPS next Y10.37% ROA- Target Price12.05 Perf Year-5.42%
Cash/sh1.47 P/C7.97 EPS next 5Y20.00% ROE- 52W Range6.59 - 12.93 Perf YTD5.88%
Dividend- P/FCF- EPS past 5Y21.10% ROI3.80% 52W High-9.51% Beta2.02
Dividend %- Quick Ratio4.30 Sales past 5Y10.90% Gross Margin49.50% 52W Low77.54% ATR0.46
Employees517 Current Ratio4.30 Sales Q/Q29.20% Oper. Margin- RSI (14)58.79 Volatility3.84% 4.00%
OptionableYes Debt/Eq0.43 EPS Q/Q111.20% Profit Margin- Rel Volume0.73 Prev Close11.50
ShortableYes LT Debt/Eq0.43 EarningsMar 08 AMC Payout- Avg Volume385.12K Price11.70
Recom2.00 SMA205.36% SMA505.70% SMA20029.06% Volume280,239 Change1.74%
Feb-08-17Initiated Oppenheimer Outperform $14
Aug-11-16Initiated Loop Capital Hold $9
Jun-02-16Initiated Compass Point Neutral $9
Feb-26-16Upgrade Goldman Sell → Neutral
Feb-25-16Downgrade Topeka Capital Markets Buy → Hold $19 → $9
Feb-25-16Downgrade RBC Capital Mkts Outperform → Sector Perform $16 → $9
Feb-08-16Initiated Sidoti Buy
Nov-23-15Reiterated Needham Buy $14 → $20
Nov-18-15Initiated Topeka Capital Markets Buy $19
Nov-09-15Upgrade BofA/Merrill Neutral → Buy
Aug-05-15Reiterated RBC Capital Mkts Outperform $18 → $15
Jun-22-15Resumed Needham Buy $14
Jun-18-15Downgrade Sun Trust Rbsn Humphrey Buy → Neutral $18 → $12
Sep-16-14Downgrade Topeka Capital Markets Hold → Sell
Jun-05-14Upgrade RBC Capital Mkts Sector Perform → Outperform $21
Feb-14-14Reiterated Canaccord Genuity Hold $17 → $20
Oct-31-13Downgrade Stifel Buy → Hold
Sep-30-13Reiterated Stifel Buy $20 → $23
May-01-13Reiterated Needham Buy $15 → $20
Apr-12-13Upgrade Stifel Hold → Buy $17
Feb-22-17 08:30AM  Americans Losing Ground in the Battle between Debt & Savings PR Newswire
Feb-21-17 05:56PM  Bankrate, Inc. To Report Fourth Quarter And Full Year 2016 Earnings On March 8, 2017 PR Newswire
Feb-16-17 07:30PM  Bankrate: Mortgage Rates Bound Higher on Inflation Pickup PR Newswire
Feb-10-17 07:19AM  Bankrate, Inc. breached its 50 day moving average in a Bearish Manner : RATE-US : February 10, 2017
Feb-09-17 08:45AM  Americans Overoptimistic About Homeownership This Year PR Newswire
07:30AM  Bankrate: Mortgage Rates Pull Back on Political Uncertainty PR Newswire
Feb-08-17 06:43AM  Coverage initiated on Bankrate by Oppenheimer
Feb-02-17 07:30AM  Bankrate: Mortgage Rates Slightly Changed as Fed Holds Steady PR Newswire
Feb-01-17 02:51PM  Bankrate, Inc. Value Analysis (NYSE:RATE) : February 1, 2017
Jan-31-17 07:16AM  Bankrate, Inc. breached its 50 day moving average in a Bearish Manner : RATE-US : January 31, 2017
Jan-26-17 07:20AM  Bankrate: Mortgage Rates Return to Highest Level in More than 2 Years PR Newswire
Jan-24-17 08:30AM  Fears Grow Over Rising Interest Rates PR Newswire
Jan-19-17 07:30AM  Bankrate: Mortgage Rates Fall for 3rd Consecutive Week PR Newswire
Jan-12-17 08:45AM  Nearly 60% of Americans Can't Afford Common Unexpected Expenses PR Newswire
07:30AM  Bankrate: Mortgage Rates Inch Lower PR Newswire
Jan-05-17 07:30AM  Bankrate: Mortgage Rates Slide to Start 2017 PR Newswire
Dec-29-16 11:30AM  Social Media Laggards Ready for the January Effect (TWTR, P) at Investopedia
07:30AM  Bankrate: Mortgage Rates Notch Higher for 9th Consecutive Week PR Newswire
Dec-22-16 07:30AM  Bankrate: Mortgage Rates Hit 27-Month High PR Newswire
Dec-20-16 10:15AM  3 reasons why half of American workers are not using their vacation time at CNBC +5.21%
Dec-19-16 02:02PM  ETFs with exposure to Bankrate, Inc. : December 19, 2016
08:30AM  52% of Working Americans Will Give Up Vacation Days this Year PR Newswire
Dec-15-16 07:30AM  Bankrate: Mortgage Rates Continue to Climb PR Newswire
Dec-13-16 10:00AM  Wallaby Financial Announces Move to New Location in Pasadena, California PR Newswire
08:30AM  Iowa is the #1 State for Drivers, California is Last PR Newswire
Dec-09-16 01:25PM  Should You Avoid Bankrate Inc (RATE)? at Insider Monkey -5.05%
Dec-08-16 08:30AM  Americans Divided on Financial Impact of the Presidential Election PR Newswire
07:30AM  Bankrate: Mortgage Rates Continue To March Higher PR Newswire
Dec-07-16 12:01AM  YOUR MONEY-Hidden credit card perks can save shoppers Reuters
Dec-01-16 07:30AM  Bankrate: Mortgage Rates Continue to Rise PR Newswire
Nov-23-16 07:30AM  Bankrate: Mortgage Rates Highest Since Early January PR Newswire
Nov-22-16 08:30AM  Fewer Than 1-in-4 Americans Plans for In-Store Shopping on Black Friday PR Newswire
Nov-18-16 09:55AM  Bankrate, Inc. :RATE-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
Nov-17-16 01:04PM  BANKRATE, INC. Financials
Nov-16-16 06:00PM  Bankrate: Mortgage Rates Show Biggest Weekly Increase Since June 2013 PR Newswire
Nov-15-16 08:30AM  48% of Americans Have Seen Their Pay Increase over the Past Year PR Newswire
Nov-12-16 03:30PM  'Trump And Dump' Scenarios As The Post-Election Rally Fades
Nov-10-16 08:30AM  Americans are Divided on Holiday Gift Preferences PR Newswire
Nov-09-16 05:28PM  Bankrate: Mortgage Rates Spike After Trump Victory PR Newswire
Nov-08-16 05:31PM  BANKRATE, INC. Files SEC form 10-Q, Quarterly Report
12:34PM  ETFs with exposure to Bankrate, Inc. : November 8, 2016
Nov-07-16 03:09PM  Bankrate, Inc.: Strong price momentum but will it sustain? +8.93%
07:03AM  Bankrate, Inc. breached its 50 day moving average in a Bullish Manner : RATE-US : November 7, 2016
Nov-04-16 03:58PM  Bankrate (RATE) Stock Advances on Q3 Beat, Raised Outlook at TheStreet +16.67%
Nov-03-16 07:53PM  Edited Transcript of RATE earnings conference call or presentation 3-Nov-16 9:00pm GMT
05:27PM  Bankrate Inc. beats 3Q profit forecasts AP
05:00PM  Bankrate Inc Earnings Call scheduled for 5:00 pm ET today
04:17PM  BANKRATE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  Bankrate Reports Third Quarter 2016 Financial Results PR Newswire
07:30AM  Bankrate: Mortgage Rates Inch Higher PR Newswire
07:07AM  Q3 2016 Bankrate Inc Earnings Release - After Market Close
Nov-01-16 10:00AM  Wallaby Financial App for Android Leverages Geo-location Technology to Maximize Reward Earnings Opportunities PR Newswire
Oct-28-16 08:00AM  Bankrate Schedules Conference Call Announcing Third Quarter 2016 Earnings PR Newswire
Oct-27-16 07:30AM  Bankrate: Mortgage Rates Mostly Unchanged PR Newswire
Oct-25-16 08:02AM  Bankrate, Inc. breached its 50 day moving average in a Bullish Manner : RATE-US : October 25, 2016
Oct-24-16 01:35PM  South Floridians among worst in the nation for saving money at bizjournals.com
08:30AM  Best/Worst Metro Areas for Building Wealth PR Newswire
Oct-21-16 04:45PM  How to avoid paying bank fees
Oct-18-16 08:30AM  65% of Americans are Limiting Their Monthly Spending PR Newswire
Oct-13-16 07:30AM  Bankrate: Mortgage Rates Jump to 4-Week High PR Newswire
Oct-12-16 04:30PM  Diller's IAC Remains Most Likely Buyer for Angie's List at TheStreet
08:06AM  Bankrate, Inc. breached its 50 day moving average in a Bearish Manner : RATE-US : October 12, 2016
Oct-11-16 09:05AM  41 Million Americans Have Had Identities Stolen PR Newswire
Oct-07-16 12:21PM  Board Shakeup at Angie's List Continues at TheStreet
Oct-06-16 07:30AM  Bankrate: Mortgage Rates Notch Higher PR Newswire
Oct-04-16 08:30AM  ATM Fees Set New Record High; Overdraft Fees Are Down PR Newswire
Oct-03-16 05:58PM  Small Cap Stocks' Pricing Overhaul at Investopedia
Sep-29-16 07:30AM  Bankrate: Mortgage Rates Fall to Nearly 3-Month Lows PR Newswire
Sep-23-16 08:07AM  Bankrate, Inc. breached its 50 day moving average in a Bullish Manner : RATE-US : September 23, 2016
Sep-22-16 07:30AM  Bankrate: Mortgage Rates Down Slightly PR Newswire +5.75%
Sep-15-16 11:38AM  Former Bankrate executives must face SEC fraud lawsuit Reuters
Sep-13-16 08:30AM  Americans Say the Presidential Election is the Biggest Threat to the U.S. Economy PR Newswire
07:32AM  Is Bankrate (RATE) Stock a Solid Choice Right Now?
Sep-08-16 07:30AM  Bankrate: Mortgage Rates Stay the Course PR Newswire
Sep-07-16 08:00AM  7 in 10 Americans Plan on Working during Retirement PR Newswire
Sep-05-16 08:09AM  Bankrate, Inc. breached its 50 day moving average in a Bullish Manner : RATE-US : September 5, 2016
Sep-02-16 05:32PM  BANKRATE, INC. Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements and Exh
Sep-01-16 07:30AM  Bankrate: Mortgage Rates in Summer Doldrums PR Newswire
Aug-31-16 09:05AM  Best and Worst Metro Areas for Homeowners PR Newswire
Aug-25-16 07:30AM  Bankrate: Mortgage Rates Show Little Change PR Newswire
Aug-18-16 07:30AM  Bankrate: Mortgage Rates in Holding Pattern PR Newswire
Aug-16-16 08:30AM  31 Million American Workers Are Saving More for Retirement PR Newswire
Aug-11-16 10:54AM  Bankrate's New Management Addresses Legal, Regulatory Issues
07:30AM  Bankrate: Mortgage Rates Remain at 2nd Lowest Level of 2016 PR Newswire
Aug-10-16 03:42PM  ETFs with exposure to Bankrate, Inc. : August 10, 2016
11:32AM  Bankrate, Inc. :RATE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
Aug-09-16 08:30AM  Hawaii Has the Highest Closing Costs, Pennsylvania Has the Lowest PR Newswire
08:05AM  Bankrate, Inc. breached its 50 day moving average in a Bullish Manner : RATE-US : August 9, 2016
Aug-08-16 06:04AM  BANKRATE, INC. Files SEC form 10-Q, Quarterly Report +9.43%
Aug-04-16 05:51PM  Bankrate Inc. reports 2Q loss AP
05:00PM  Bankrate Inc Earnings Call scheduled for 5:00 pm ET today
04:16PM  Bankrate Says Credit Card Segment Set All-Time Record High
04:14PM  BANKRATE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  Bankrate Reports Second Quarter 2016 Financial Results PR Newswire
07:30AM  Bankrate: Mortgage Rates Slump on News of Disappointing Economic Growth PR Newswire
07:07AM  Q2 2016 Bankrate Inc Earnings Release - After Market Close
Aug-01-16 08:30AM  Nearly 9 in 10 College Graduates Say College is a Good Investment PR Newswire
Jul-28-16 05:50PM  Bankrate Schedules Conference Call Announcing Second Quarter 2016 Earnings PR Newswire
07:30AM  Bankrate: Mortgage Rates Continue Post-Brexit Rebound PR Newswire
Jul-21-16 07:30AM  Bankrate: Mortgage Rates Nose Higher PR Newswire
Bankrate, Inc. operates as a publisher, aggregator, and distributor of personal finance content on the Internet. It provides personal finance editorial content across various categories, including mortgages, deposits, credit cards, senior care, and other personal finance categories. The company's flagship Websites Bankrate.com, CreditCards.com, and Caring.com are content destinations and connect its audience with contextually relevant advertisers, and financial service and senior care providers. Its Banking segment offers information on rates for various types of mortgages, home lending, and refinancing; and rate information and original editorial content on various deposit products, retirement, taxes, and debt management. The company's Credit Cards segment offers information and comparison capabilities of consumer and business credit and prepaid cards; and host news and advice on personal finance, credit card, and bank policies, as well as tools and calculators to estimate credit scores and card benefits. Its Senior Care segment provides caregiving content, a comprehensive online senior living directory for the United States, a local directory covering a range of other senior caregiving services, and telephone support and advice from trained family advisors. Bankrate also develops and provides content, tools, Web services, and co-branded Websites to approximately 150 online partners, including personal finance sites. The company was formerly known as ilife.com Inc. and changed its name to Bankrate, Inc. in 2000. Bankrate, Inc. was founded in 1976 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GILMARTIN JAMES RSVP, General CounselMay 17Sale8.683,11927,073114,761May 17 05:00 PM
PINOLA RICHARD JDirectorMar 11Buy8.765,70049,9329,034Mar 14 05:00 PM
PINOLA RICHARD JDirectorMar 11Buy8.6711,00095,37057,899Mar 14 05:00 PM
PMC PharMerica Corporation daily Stock Chart
PMC [NYSE]
PharMerica Corporation
Index- P/E23.49 EPS (ttm)1.11 Insider Own0.30% Shs Outstand30.78M Perf Week1.17%
Market Cap800.28M Forward P/E11.87 EPS next Y2.19 Insider Trans0.00% Shs Float29.52M Perf Month4.21%
Income34.10M PEG4.84 EPS next Q0.51 Inst Own97.80% Short Float3.21% Perf Quarter7.44%
Sales2.08B P/S0.39 EPS this Y414.20% Inst Trans-1.18% Short Ratio5.56 Perf Half Y15.81%
Book/sh17.42 P/B1.49 EPS next Y17.42% ROA2.90% Target Price28.50 Perf Year-12.04%
Cash/sh0.21 P/C123.12 EPS next 5Y4.85% ROE6.50% 52W Range19.20 - 31.02 Perf YTD3.38%
Dividend- P/FCF121.25 EPS past 5Y12.40% ROI4.40% 52W High-16.18% Beta1.15
Dividend %- Quick Ratio2.20 Sales past 5Y1.90% Gross Margin15.80% 52W Low35.42% ATR0.66
Employees5800 Current Ratio3.10 Sales Q/Q2.80% Oper. Margin2.30% RSI (14)56.62 Volatility2.41% 2.71%
OptionableYes Debt/Eq0.73 EPS Q/Q142.00% Profit Margin1.60% Rel Volume1.69 Prev Close26.40
ShortableYes LT Debt/Eq0.71 EarningsFeb 24 BMO Payout0.00% Avg Volume170.51K Price26.00
Recom2.30 SMA202.82% SMA502.07% SMA2001.91% Volume287,541 Change-1.52%
Jun-07-16Resumed BofA/Merrill Buy
May-10-16Reiterated Barrington Research Outperform $30 → $34
Mar-16-16Initiated Credit Suisse Outperform
Mar-14-16Downgrade UBS Buy → Neutral $40 → $22
Feb-29-16Reiterated Barrington Research Outperform $39 → $30
Feb-29-16Reiterated Barclays Underweight $27 → $22
Aug-10-15Upgrade UBS Neutral → Buy $31 → $40
Aug-10-15Reiterated Barrington Research Outperform $33 → $38
Jan-13-14Reiterated Barclays Underweight $16 → $20
Jan-08-14Reiterated Barclays Underweight $14 → $16
Feb-11-13Downgrade RBC Capital Mkts Outperform → Sector Perform
Apr-25-12Reiterated UBS Neutral $15 → $13
Oct-03-11Reiterated UBS Neutral $13 → $15
Apr-28-11Downgrade Stifel Nicolaus Buy → Hold
Jan-19-11Reiterated Oppenheimer Perform $12 → $14
Nov-08-10Reiterated Oppenheimer Perform $10 → $12
Sep-21-10Reiterated UBS Neutral $13 → $10.50
Aug-18-10Downgrade Barclays Capital Overweight → Equal Weight $19 → $10
Aug-09-10Downgrade RBC Capital Mkts Outperform → Sector Perform $19 → $10
Jul-02-10Reiterated UBS Neutral $19 → $16
Feb-14-17 08:25AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : February 14, 2017
Feb-03-17 04:30PM  PharMerica Corporation Announces Fourth Quarter and Year End 2016 Earnings Call and Webcast Business Wire
Feb-01-17 05:09PM  PHARMERICA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jan-31-17 09:00AM  PharMerica Appoints Robert E. Dries as Executive Vice President and Chief Financial Officer Business Wire
Jan-24-17 10:36AM  PharMerica Corp. Value Analysis (NYSE:PMC) : January 24, 2017
Jan-23-17 07:36AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : January 23, 2017
Dec-19-16 08:27AM  PharMerica Amends Credit Facility, Ups Borrowing Capacity
Dec-15-16 04:51PM  PHARMERICA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial S
04:15PM  PharMerica Announces Expansion of Existing Credit Facility, Increasing Borrowing Capacity by $150 Million Business Wire
Dec-09-16 01:53PM  ETFs with exposure to PharMerica Corp. : December 9, 2016
07:22AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : December 9, 2016
Dec-05-16 02:22PM  Should You Avoid PharMerica Corporation (PMC)? at Insider Monkey
Nov-18-16 10:47AM  PharMerica Corp. :PMC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
Nov-17-16 01:04PM  PHARMERICA CORP Financials
Nov-09-16 11:00AM  Edited Transcript of PMC earnings conference call or presentation 9-Nov-16 3:00pm GMT +11.06%
10:00AM  PharMerica Corp Earnings Call scheduled for 10:00 am ET today
08:09AM  PharMerica misses 3Q profit forecasts
08:03AM  PHARMERICA CORP Files SEC form 10-Q, Quarterly Report
08:01AM  PHARMERICA CORP Files SEC form 8-K, Results of Operations and Financial Condition
08:00AM  PharMerica Reports Third Quarter 2016 Results Business Wire
07:07AM  Q3 2016 PharMerica Corp Earnings Release - Before Market Open
Oct-31-16 08:32AM  PharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : October 31, 2016
Oct-14-16 04:30PM  PharMerica Corporation Announces Third Quarter 2016 Earnings Call and Webcast Business Wire
Aug-31-16 08:33AM  5 Health Care Stocks John Paulson Is Betting On in 2016
Aug-30-16 11:20AM  What can Pharmerica do to get buyers to swipe right? at bizjournals.com
Aug-25-16 04:14PM  PharMerica Corp.: Strong price momentum but will it sustain?
08:05AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : August 25, 2016
Aug-24-16 08:23PM  Why PharMerica Soared 13.4% Today at Motley Fool +13.39%
05:03PM  Report: Louisville's Pharmerica may sell at bizjournals.com
03:50PM  PharMerica (PMC) Stock Soars, Exploring Possible Sale
01:40PM  [$$] PharMerica Exploring Strategic Alternatives, Including Sale at The Wall Street Journal
11:03AM  Specialty pharmacy PharMerica explores possible sale -sources Reuters
Aug-23-16 12:19PM  ETFs with exposure to PharMerica Corp. : August 23, 2016
Aug-12-16 12:15PM  PharMerica Corp. :PMC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-11-16 01:03PM  ETFs with exposure to PharMerica Corp. : August 11, 2016
08:46AM  One of Pharmerica's top execs plans to retire at bizjournals.com
08:16AM  PharMerica (PMC) Q2 Earnings in Line, Revenues Beat
Aug-10-16 03:07PM  PHARMERICA CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Principal -6.85%
08:14AM  PharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : August 10, 2016
Aug-09-16 11:32AM  Edited Transcript of PMC earnings conference call or presentation 9-Aug-16 2:00pm GMT -7.19%
10:00AM  PharMerica Corp Earnings Call scheduled for 10:00 am ET today
09:30AM  The Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways
08:09AM  PharMerica meets 2Q profit forecasts
08:01AM  PHARMERICA CORP Files SEC form 8-K, Results of Operations and Financial Condition
08:01AM  PharMerica Corporation Announces Planned Retirement of Chief Financial Officer David W. Froesel, Jr. Business Wire
08:00AM  PharMerica Reports Second Quarter 2016 Results Business Wire
07:07AM  Q2 2016 PharMerica Corp Earnings Release - Before Market Open
Aug-08-16 09:09AM  Healthcare Stocks' Aug 9 Earnings Roster: XON, PMC & More
Jul-18-16 04:10PM  PharMerica Corp. Value Analysis (NYSE:PMC) : July 18, 2016
Jul-14-16 04:15PM  PharMerica Corporation Announces Second Quarter 2016 Earnings Call and Webcast Business Wire
Jul-11-16 10:57AM  Looking for Bargain Stocks? Pick These 5 with Low P/B Ratio
09:29AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : July 11, 2016
Jul-08-16 10:25AM  Can AngioDynamics' (ANGO) Q4 Earnings Pull a Surprise?
09:30AM  Zacks.com featured highlights: DeVry Education Group, PharMerica, Trinity Industries, Select Medical and Tower International
Jul-07-16 09:29AM  5 Low Price-to-Cash-Flow Stocks for Assured Returns
Jul-06-16 09:40AM  Should Davita's (DVA) Stock Be in Your Portfolio Now?
Jul-05-16 04:10PM  5 Cheap Value Stocks for Investors in July
Jun-30-16 09:30AM  Zacks.com featured highlights: Tallgrass Energy GP, Harsco, PharMerica, Dave & Buster's Entertainment and McDermott International
Jun-29-16 08:17AM  5 Stocks with Earnings Beat Potential to Buy Now
12:09AM  Two Small-Cap Healthcare Stocks That are Cheap Buys Right Now
Jun-22-16 09:30AM  Zacks.com featured highlights: Dean Foods, PharMerica, Tower International, Ford Motor and Carnival
Jun-21-16 04:08PM  PHARMERICA CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
11:08AM  5 Medical Stocks with Incredibly Low PEG Ratios
08:46AM  5 Low Price-to-Cash-Flow Stocks with High Return Prospects
Jun-17-16 09:30AM  Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
Jun-16-16 09:14AM  Bet on These 5 Stocks with Upgraded Broker Ratings
Jun-15-16 08:40AM  Why the Earnings Streak Will Continue for PharMerica (PMC)
Jun-13-16 10:20AM  5 Best Low-Beta Stocks to Buy as Volatility Hits a 3-Month High
08:22AM  Hedge Funds Favorite Stocks With Low Price-to-Cash-Flow Ratios at Insider Monkey
Jun-08-16 06:42AM  Chemed Posts Balanced Growth amid Coding Change Issues
Jun-07-16 09:30AM  The Zacks Analyst Blog Highlights: JinkoSolar Holding, Carnival, PharMerica, Air Methods and Tower International
08:42AM  Surging Earnings Estimates Signal Good News for PharMerica (PMC)
Jun-06-16 01:13PM  5 Stocks with Impressive Price-to-Cash-Flow Ratio
May-23-16 04:07PM  DaVita to Expand in Orlando with Family Health Care Buyout
12:39PM  Is PharMerica Corporation (PMC) a Good Stock to Buy? at Insider Monkey
May-19-16 03:08PM  7 Low Price-to-Cash-Flow Stocks to Fetch Higher Returns
May-18-16 09:30AM  PharMerica, AbbVie, Red Robin Gourmet Burgers, Habit Restaurants and Shake Shack highlighted as Zacks Bull and Bear of the Day
May-17-16 11:50AM  PharMerica wants the Supreme Court to rethink this decision at bizjournals.com
08:00AM  PharMerica to Present at the UBS Global HealthCare Conference Business Wire
May-13-16 09:05AM  Pharmerica's growth strategy is really generic at bizjournals.com
May-12-16 11:26AM  PharMerica Corp. :PMC-US: Earnings Analysis: Q1, 2016 By the Numbers
May-06-16 02:20PM  PharMerica's 1Q earnings fell sharply but beat expectations at bizjournals.com +9.98%
11:07AM  Edited Transcript of PMC earnings conference call or presentation 6-May-16 2:00pm GMT
10:00AM  PharMerica Corp Earnings Call scheduled for 10:00 am ET today
08:08AM  PharMerica beats 1Q profit forecasts AP
08:01AM  PHARMERICA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
08:00AM  PharMerica Reports First Quarter 2016 Results Business Wire
07:07AM  Q1 2016 PharMerica Corp Earnings Release - Before Market Open CCBN
May-02-16 04:57PM  PharMerica to Present at the Bank of America Merrill Lynch 2016 Health Care Conference Business Wire
Apr-19-16 08:07AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : April 19, 2016
Apr-13-16 03:25PM  PharMerica ordered to pay $48.5 million in drug deal gone wrong at bizjournals.com
Apr-12-16 04:15PM  PharMerica Corporation Announces First Quarter 2016 Earnings Call and Webcast Business Wire
Apr-04-16 04:51PM  PHARMERICA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  PharMerica Provides Update on AmerisourceBergen Litigation Business Wire
Mar-29-16 04:36PM  PharMerica Announces Date of 2016 Annual Meeting of Shareholders at noodls
04:15PM  PharMerica Announces Date of 2016 Annual Meeting of Shareholders Business Wire
11:04AM  ETFs with exposure to PharMerica Corp. : March 29, 2016
Mar-24-16 01:40PM  PharMerica execs could get big bonus checks at bizjournals.com
Mar-23-16 05:03PM  PHARMERICA CORP Files SEC form 8-K, Change in Directors or Principal Officers
Mar-16-16 07:11AM  Coverage initiated on PharMerica by Credit Suisse
PharMerica Corporation operates as an institutional pharmacy services company in the United States. The company offers services to healthcare facilities; pharmacy management services to hospitals; specialty infusion services to patients outside hospitals; and oncology pharmacy services. It purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. The company also provides hospital pharmacy management services, including hospital pharmacy operations, regulatory and financial management services, and clinical pharmacy programs; and consultant pharmacist services and medical records services. It operates 94 institutional, 17 specialty infusion, and 5 specialty oncology pharmacies in 45 states. The company serves institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, individuals receiving in-home care, and other long-term alternative care providers. PharMerica Corporation was founded in 2006 and is headquartered in Louisville, Kentucky.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MEYERS GEOFFREY GDirectorOct 31Option Exercise15.0629,268440,77672,943Nov 03 05:47 PM
DAC Danaos Corporation daily Stock Chart
DAC [NYSE]
Danaos Corporation
Index- P/E3.28 EPS (ttm)0.79 Insider Own58.70% Shs Outstand109.81M Perf Week0.00%
Market Cap285.51M Forward P/E2.39 EPS next Y1.09 Insider Trans0.00% Shs Float19.58M Perf Month-3.70%
Income86.90M PEG1.09 EPS next Q0.20 Inst Own2.30% Short Float1.73% Perf Quarter-22.39%
Sales529.50M P/S0.54 EPS this Y-12.40% Inst Trans-6.38% Short Ratio6.14 Perf Half Y-27.58%
Book/sh8.43 P/B0.31 EPS next Y-14.17% ROA2.40% Target Price3.00 Perf Year-44.56%
Cash/sh1.17 P/C2.23 EPS next 5Y3.00% ROE9.70% 52W Range2.15 - 4.90 Perf YTD-1.89%
Dividend- P/FCF- EPS past 5Y22.70% ROI6.80% 52W High-46.94% Beta1.04
Dividend %- Quick Ratio0.10 Sales past 5Y9.60% Gross Margin76.50% 52W Low20.93% ATR0.13
Employees1223 Current Ratio0.10 Sales Q/Q-22.60% Oper. Margin36.20% RSI (14)49.44 Volatility3.43% 5.08%
OptionableNo Debt/Eq2.80 EPS Q/Q-120.00% Profit Margin16.40% Rel Volume0.99 Prev Close2.70
ShortableNo LT Debt/Eq0.00 EarningsFeb 21 AMC Payout0.00% Avg Volume55.23K Price2.60
Recom3.00 SMA200.02% SMA50-3.27% SMA200-16.66% Volume54,747 Change-3.70%
Feb-20-15Initiated Global Hunter Securities Neutral
Sep-18-14Resumed Clarkson Capital Hold
Apr-17-13Initiated Global Hunter Securities Neutral
Apr-24-09Downgrade Jefferies & Co Buy → Hold $6 → $5
Mar-13-09Reiterated Jefferies & Co Buy $22 → $6
Nov-04-08Reiterated Jefferies & Co Buy $46 → $22
Jan-29-08Initiated Oppenheimer Outperform $36
Nov-20-07Initiated Lazard Capital Buy $39
Jul-18-07Initiated Credit Suisse Outperform $37
Jan-25-07Reiterated Fortis Bank Buy $23 → $27
Feb-21-17 06:04PM  Danaos reports 4Q loss
04:30PM  Danaos Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2016 PR Newswire
07:07AM  Q4 2016 Danaos Corp Earnings Release - After Market Close
Feb-15-17 04:30PM  Danaos Corporation Announces Date for the Release of Fourth Quarter 2016 Results, Conference Call and Webcast PR Newswire
Dec-22-16 11:07AM  What Makes Danaos (DAC) a Strong Sell?
Dec-16-16 11:30AM  DryShips Shares Float Higher Again With New Loan
Dec-15-16 04:40PM  Danaos reports 3Q loss +5.17%
04:30PM  Danaos Corporation Reports Third Quarter and Nine Months Results for the Period Ended September 30, 2016 PR Newswire
07:07AM  Q3 2016 Danaos Corp Earnings Release - After Market Close
Dec-13-16 04:48PM  Danaos Corporation Announces Date for the Release of Third Quarter 2016 Results, Conference Call and Webcast PR Newswire
Nov-21-16 08:26AM  Shipping Stocks' Q3 Earnings Round the Corner: GOGL, DAC
Nov-16-16 06:08PM  Why Fossil Group, Advanced Micro Devices, and Danaos Jumped Today at Motley Fool +8.96%
03:24PM  Danaos Corp.: Price momentum supported by strong fundamentals
07:39AM  Danaos Corp. breached its 50 day moving average in a Bullish Manner : DAC-US : November 16, 2016
Nov-15-16 04:02PM  Why Shipping Stocks Skyrocketed Higher Today at Motley Fool +42.55%
Nov-08-16 09:39AM  Best of the Worst: Can We Find a Container Shipping Company to Invest In? at Motley Fool -8.00%
Nov-07-16 07:27AM  Transport Stock Earnings to Watch on Nov 8 - EXPD, TGH, DAC
Oct-10-16 09:00AM  Capital Link's 6th Annual Operational Excellence & Maritime CSR Forum Wednesday, November 2, 2016 in London, UK Marketwired
Sep-09-16 04:26PM  Danaos Corp.: Price momentum supported by strong fundamentals
Sep-01-16 08:00AM  Danaos Corporation Receives Notice that Counterparty has Entered into Court Receivership PR Newswire -11.46%
Aug-30-16 01:45PM  Will Seaspan Corporation Raise Its Dividend in 2017? at Motley Fool
Aug-18-16 08:09AM  Danaos Corp. breached its 50 day moving average in a Bearish Manner : DAC-US : August 18, 2016
Aug-15-16 04:15PM  3 Things Seaspan Corporation's CEO Wants You to Know at Motley Fool
Aug-11-16 05:24AM  Navigator Holdings (NVGS) in Focus: Stock Up 7% in Session
Aug-10-16 01:11PM  Danaos Corp. :DAC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
08:34AM  Should You Get Rid of Kirby (KEX) Now?
Aug-03-16 09:30AM  Zacks.com featured highlights: Danaos, Telecom Italia, Fibria Celulose, Goodyear Tire & Rubber and Zafgen
08:25AM  Ardmore Shipping (ASC) in Focus: Stock Moves 9.4% Higher
Aug-01-16 05:06PM  Danaos posts 2Q profit
04:30PM  Danaos Corporation Reports Second Quarter and Half Year Results for the Period Ended June 30, 2016 PR Newswire
07:07AM  Q2 2016 Danaos Corp Earnings Release - After Market Close
Jul-29-16 08:39AM  Transport Stocks' Q2 Earnings on Aug 1: DAC, RAIL & Others
Jul-25-16 08:51AM  What Makes Navigator Holdings (NVGS) a Strong Sell?
Jul-21-16 04:30PM  Danaos Corporation Announces Date for the Release of Second Quarter 2016 Results, Conference Call and Webcast Marketwired
Jul-20-16 08:05AM  Star Bulk Carriers (SBLK) in Focus: Stock Up 5.3% in Session +5.57%
Jul-19-16 09:30AM  Zacks.com featured highlights: Stamps.com, ReneSola and Danaos
08:30AM  Capital Product (CPLP) Soars: Stock Adds 7.6% in Session
Jul-18-16 03:39PM  Danaos Corp. Value Analysis (NYSE:DAC) : July 18, 2016 +7.43%
Jul-12-16 06:53AM  Can the Rally in Danaos (DAC) Shares Continue?
Jul-11-16 08:54AM  Danaos Corp. breached its 50 day moving average in a Bullish Manner : DAC-US : July 11, 2016 +5.94%
Jul-08-16 08:35AM  Aegean Marine Petroleum (ANW) in Focus: Stock Jumps 5.6% +23.17%
08:05AM  3 Reasons Why Danaos Corporation (DAC) is a Great Value Stock
Jul-07-16 08:58AM  Why Scorpio Tankers (STNG) Could Be Positioned for a Slump +11.19%
08:25AM  Danaos (DAC) Shows Strength: Stock Adds 8.5% in Session
Jun-21-16 10:29AM  Maersk battles to stay on top as container shipping downturn deepens
Jun-17-16 03:15PM  Seaspan Corporation Refuses to Throw a Lifeline to a Sinking Customer at Motley Fool
May-31-16 10:05AM  Has Seaspan Corporation Done Enough to Shore Up Its Finances? at Motley Fool
May-23-16 04:14PM  Danaos Corp.: Price momentum supported by strong fundamentals -5.48%
May-10-16 09:05AM  Industry Leaders at Capital Link's Analyst & Investor Day on June 6, 2016 at Athens, Greece Marketwired
May-06-16 11:29AM  Danaos Corp. :DAC-US: Earnings Analysis: Q1, 2016 By the Numbers -12.95%
May-04-16 06:42PM  Danaos posts 1Q profit +6.10%
04:30PM  Danaos Corporation Reports First Quarter Results for the Period Ended March 31, 2016 Marketwired
07:07AM  Q1 2016 Danaos Corp Earnings Release - After Market Close
Apr-21-16 04:39PM  Danaos Corporation Announces Date for the Release of First Quarter 2016 Results, Conference Call and Webcast Marketwired
Mar-29-16 04:14PM  Greek Billionaire George Economou Buys More Shares of Danaos Corp (DAC) at Insider Monkey
Mar-19-16 01:04PM  DANAOS CORP Financials
Mar-18-16 08:30AM  Danaos Corporation Announces Availability of Its Annual Report on Form 20-F for the Year Ended December 31, 2015 Marketwired
Feb-18-16 10:28AM  Danaos Corp. Earnings Analysis: 2015 By the Numbers
Feb-16-16 05:23PM  Danaos beats 4Q profit forecasts
04:46PM  Danaos Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2015 Marketwired
07:07AM  Q4 2015 Danaos Corp Earnings Release - After Market Close
Feb-10-16 09:30AM  New Strong Buy Stocks for February 10th
Feb-02-16 05:24PM  Danaos Corp. Value Analysis (NYSE:DAC) : February 2, 2016
08:05AM  Navigator Holdings (NVGS) in Focus: Stock Rises 6.5%
08:02AM  Danaos Corp. breached its 50 day moving average in a Bullish Manner : February 2, 2016
Feb-01-16 09:10AM  Danaos Corporation Announces Date for the Release of Fourth Quarter 2015 Results, Conference Call and Webcast at noodls
09:00AM  Danaos Corporation Announces Date for the Release of Fourth Quarter 2015 Results, Conference Call and Webcast Marketwired
Jan-22-16 08:30AM  KNOT Offshore Partners (KNOP) Jumps: Stock Rises 6.7%
Jan-21-16 08:40AM  Capital Product Partners (CPLP) Jumps: Stock Rises 5.6%
Jan-15-16 02:43PM  Edited Transcript of DAC earnings conference call or presentation 4-Nov-15 2:00pm GMT -5.49%
Jan-13-16 09:30AM  The Zacks Analyst Blog Highlights: Aegean Marine Petroleum Network, Danaos, Tsakos Energy Navigation, Horizon Pharma and ICON Public Limited
Jan-12-16 02:18PM  5 Smart PIIGS Stocks to Buy Now
Jan-01-16 08:01AM  Danaos Corp. breached its 50 day moving average in a Bullish Manner : January 1, 2016
Dec-31-15 04:13PM  Danaos Corp.: Strong price momentum but will it sustain? +8.12%
08:25AM  Danaos Corporation (DAC) Looks Good: Stock Adds 14.9%
Dec-30-15 08:30AM  Diana Containerships (DCIX) Looks Good: Stock Up 5.3% +14.94%
Dec-18-15 09:48AM  Danaos Corp. Earnings Analysis: Q3, 2015 By the Numbers
08:30AM  Teekay Corporation (TK) in Focus: Stock Plunges 58.4%
Dec-14-15 08:55AM  Danaos Corp Stock: 3 Reasons Why DAC Is a Top Choice for Value Investors
Dec-09-15 08:05AM  Navios Maritime (NMM) in Focus: Stock Moves 15.1% Higher
Dec-08-15 02:28PM  REMINDER - Capital Link's 9th Annual Global Shipping Markets Roundtable Marketwired
08:42AM  Teekay Offshore (TOO) Crumbles: Stock Falls by 11.9%
08:36AM  Weakness Seen in Teekay LNG (TGP): Stock Slumps 12.8%
Dec-02-15 09:12AM  Capital Link's 9th Annual Global Shipping Markets Roundtable Marketwired
Nov-23-15 05:18PM  Beyond Virgin America: 4 Transportation Stocks That Hold Promise
Nov-16-15 09:30AM  The Zacks Analyst Blog Highlights: Huaneng Power International, Danaos, Tesoro, General Motors and Marathon Petroleum
Nov-13-15 08:47AM  Better Safe than Sorry: Buy These 5 Stocks with P/Es Below 10
08:34AM  Can Danaos (DAC) Keep the Earnings Streak Alive This Quarter?
Nov-10-15 11:04AM  Danaos Corp. breached its 50 day moving average in a Bearish Manner : November 10, 2015
Nov-03-15 05:43PM  Danaos tops Street 3Q forecasts
04:15PM  Danaos Corporation Reports Third Quarter and Nine Months Results for the Period Ended September 30, 2015 Marketwired
07:07AM  Q3 2015 Danaos Corp Earnings Release - After Market Close
Oct-29-15 09:28AM  Danaos Corp. breached its 50 day moving average in a Bearish Manner : October 29, 2015
Oct-21-15 11:56AM  23 Shipping & Offshore Companies Presenting at Capital Link's Operational Excellence - Sustainability Forum Marketwired
Oct-13-15 04:15PM  Danaos Corporation Announces Date for the Release of Third Quarter 2015 Results, Conference Call and Webcast Marketwired
Oct-09-15 09:30AM  The Zacks Analyst Blog Highlights: Scientific Games, Exterran Partners, Matson, Danaos and Spectra Energy Partners
Oct-08-15 11:11AM  5 Stocks to Survive a Rough Earnings Season
Oct-07-15 08:43AM  3 Reasons Why Danaos Corporation (DAC) is a Great Value Stock
Oct-05-15 08:38AM  Why Danaos Corporation (DAC) Could Beat Earnings Estimates Again
08:30AM  3 Reasons Momentum Stock Investors Will Love Danaos Corporation (DAC)
Danaos Corporation, together with its subsidiaries, owns and operates containerships in Greece and internationally. The company offers seaborne transportation services, as well as charters its vessels to liner companies. As of March 18, 2016, it had a fleet of 59 containerships aggregating 353,586 twenty foot equivalent units. The company was formerly known as Danaos Holdings Limited and changed its name to Danaos Corporation in October 2005. Danaos Corporation was founded in 1972 and is based in Piraeus, Greece.
ACOR Acorda Therapeutics, Inc. daily Stock Chart
ACOR [NASD]
Acorda Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.76 Insider Own1.80% Shs Outstand46.11M Perf Week5.87%
Market Cap1.16B Forward P/E15.34 EPS next Y1.65 Insider Trans-24.44% Shs Float45.30M Perf Month21.98%
Income-34.60M PEG- EPS next Q0.09 Inst Own- Short Float9.98% Perf Quarter18.54%
Sales519.60M P/S2.24 EPS this Y-401.70% Inst Trans-1.44% Short Ratio6.13 Perf Half Y-2.66%
Book/sh14.60 P/B1.73 EPS next Y59.19% ROA-2.70% Target Price33.10 Perf Year-25.63%
Cash/sh- P/C- EPS next 5Y29.00% ROE-5.20% 52W Range16.40 - 37.36 Perf YTD34.31%
Dividend- P/FCF- EPS past 5Y-24.60% ROI-2.90% 52W High-32.41% Beta1.63
Dividend %- Quick Ratio0.50 Sales past 5Y12.20% Gross Margin79.20% 52W Low53.96% ATR1.15
Employees535 Current Ratio0.50 Sales Q/Q7.40% Oper. Margin-6.90% RSI (14)68.64 Volatility4.18% 5.08%
OptionableYes Debt/Eq0.50 EPS Q/Q-132.60% Profit Margin-6.70% Rel Volume0.71 Prev Close25.30
ShortableYes LT Debt/Eq0.04 EarningsFeb 14 BMO Payout- Avg Volume736.81K Price25.25
Recom2.50 SMA2012.37% SMA5019.80% SMA2009.29% Volume522,477 Change-0.20%
Feb-15-17Upgrade Goldman Sell → Neutral
Nov-30-16Upgrade JP Morgan Neutral → Overweight
Oct-04-16Resumed Leerink Partners Mkt Perform $25
Mar-30-16Initiated Goldman Sell
Sep-01-15Initiated Raymond James Mkt Perform
Jun-09-15Initiated Guggenheim Neutral
Apr-22-15Resumed Piper Jaffray Neutral
Feb-12-15Initiated MLV & Co Buy $58
Oct-30-14Reiterated MKM Partners Neutral $31.50 → $33
Aug-19-14Resumed Stifel Buy $47
May-07-14Reiterated MKM Partners Neutral $33 → $31.50
Apr-17-14Initiated Canaccord Genuity Hold $37
Apr-14-14Upgrade FBR Capital Mkt Perform → Outperform $30 → $47
Nov-01-13Upgrade MKM Partners Sell → Neutral
Nov-01-13Reiterated FBR Capital Outperform $35 → $30
Oct-30-13Initiated FBR Capital Mkt Perform $35
Oct-01-13Reiterated Aegis Capital Buy $43 → $50
Aug-01-13Reiterated Feltl & Co. Buy $40 → $43
May-02-13Downgrade MKM Partners Neutral → Sell
Apr-16-13Reiterated MKM Partners Neutral $31 → $33
Feb-21-17 07:00AM  Catherine D. Strader, Ph.D., Joins Acorda Therapeutics Board of Directors Business Wire
Feb-16-17 01:20PM  Generic Competitors A Looming Threat For Acorda Therapeutics Inc (ACOR) at Insider Monkey
12:52PM  Acorda Therapeutics, Inc. :ACOR-US: Earnings Analysis: 2016 By the Numbers : February 16, 2017
Feb-15-17 04:45PM  Acorda Must Stave Off Mylan, Teva Generics To Protect Ampyra: RBC +6.50%
03:23PM  [2/15] Today's Top 10 Long/Short Estimize Signal Scores
10:55AM  Acorda Therapeutics, Inc. :ACOR-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017
09:42AM  Acorda (ACOR) Reports Narrower-than-Expected Loss in Q4
09:27AM  Biotech Premarket Movers: Ardelyx, Acorda Therapeutics, Medicines Co.
06:35AM  Acorda Therapeutics upgraded by Goldman
Feb-14-17 12:38PM  Edited Transcript of ACOR earnings conference call or presentation 14-Feb-17 1:30pm GMT
09:30AM  The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences
08:30AM  Acorda Therapeutics Inc Earnings Call scheduled for 8:30 am ET today
07:07AM  Q4 2016 Acorda Therapeutics Inc Earnings Release - Before Market Open
06:27AM  ACORDA THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
06:19AM  Acorda reports 4Q loss
06:00AM  Acorda Provides Financial and Pipeline Update for Fourth Quarter and Year End 2016 Business Wire
Feb-10-17 10:19AM  A Loud Coaching Session on the Desk
08:15AM  Acorda (ACOR) Catches Eye: Stock Gains 20.8% in Session
08:15AM  Blog Coverage Acorda's Stock Price Soared Above 20% on Positive Data from Parkinson Disease Late Stage Clinical Trial Accesswire
07:07AM  ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events
Feb-09-17 05:00PM  Acorda Pops To 19-Week High On Strong Parkinson's Drug Trial +20.83%
02:03PM  Acorda Parkinsons drug results shot its stock up 13%. Why Wall Street is still cautious at MarketWatch
11:07AM  Why Acorda Therapeutics Stock Is Jumping Today at Motley Fool
11:00AM  Acorda Therapeutics Stock Surges on Clinical Trial Results at TheStreet
10:38AM  Acorda Parkinsons Drug Succeeds In Phase 3 Study at Investopedia
10:25AM  Is This The Big Turnaround Acorda Needs?
09:37AM  Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson's drug at MarketWatch
09:05AM  Acorda, Amgen and Regeneron Lead Premarket Biotech Movers
07:49AM  Acorda Therapeutics Inhaled Drug Reduces Parkinson's Motor Symptoms in Late-Stage Study
06:38AM  ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:00AM  Acorda Announces Positive Phase 3 Clinical Trial Results for CVT-301 Business Wire
Feb-07-17 10:35AM  [2/7] Today's Top 10 Long/Short Estimize Signal Scores
10:00AM  Biotechnology Executives Oppose Trump Immigration Policy at Forbes
Feb-03-17 07:00AM  Acorda Therapeutics to Present at Two Investor Conferences in February Business Wire
Feb-02-17 08:42AM  Implied Volatility Surging for Acorda Therapeutics (ACOR) Stock Options
06:46AM  Allergan (AGN) Q4 Earnings: What's in Store for the Stock?
06:42AM  GlaxoSmithKline (GSK) Q4 Earnings: What's in the Cards?
Jan-31-17 07:00AM  Acorda to Host Conference Call to Discuss Fourth Quarter 2016 on February 14, 2017 Business Wire
Jan-30-17 08:31AM  Acorda Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ACOR-US : January 30, 2017
Jan-25-17 09:30AM  The Zacks Analyst Blog Highlights: RedHill Biopharma, Cempra, Vertex Pharmaceuticals, Acorda Therapeutics and Kite Pharma
Jan-24-17 12:30PM  Can Acorda Therapeutics Inc (ACOR) Give Eli Lilly And Co (LLY) A Run For Its Money In Migraine Drug Market? at Insider Monkey
08:14AM  Will These 5 Drug Stocks Be Big Winners in the Q4 Earnings Season?
Jan-23-17 05:03PM  Acorda Could Rival Lilly's 'Novel' Migraine Drug With Faster Onset
Jan-18-17 08:28AM  Kura Oncology Starts Dosing Patients in Phase II CMML Study
Jan-17-17 08:05AM  What's Behind Clovis' (CLVS) One-Year Rally of 146.3%?
Jan-09-17 06:25AM  ACORDA THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
06:00AM  Acorda Announces 2016 AMPYRA Net Sales and 2017 Financial Guidance at J.P. Morgan Healthcare Conference Business Wire
Jan-05-17 08:15AM  Post Earnings Coverage as Strongbridge Loss Narrowed; Acquires US Rights for KEYEVIS and Announced Equity Financing Accesswire
08:12AM  Acorda Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ACOR-US : January 5, 2017
Jan-03-17 02:42PM  New year, new drug prices
Dec-30-16 03:36PM  January Will Feature Some Of The Market's Most Influential Events
Dec-28-16 07:00AM  Acorda Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-21-16 09:28AM  Acorda Therapeutics, Inc. Value Analysis (NASDAQ:ACOR) : December 21, 2016
Dec-20-16 07:37AM  Acorda Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ACOR-US : December 20, 2016
Dec-14-16 11:29PM  Is Genomic Health, Inc. (GHDX) A Good Stock To Buy? at Insider Monkey
Dec-09-16 12:23PM  These small-cap stocks are expected to rise at least 31% in 2017 at MarketWatch
Dec-02-16 12:59PM  Is Kearny Financial (KRNY) A Good Stock To Buy? at Insider Monkey
Nov-28-16 10:21AM  Acorda Therapeutics Inc (ACOR) Continues To Fall From Favor With Top Investors at Insider Monkey
Nov-23-16 06:31AM  Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola
Nov-22-16 04:38PM  Biotech Movers And Shakers: Mast Therapeutics, Inc. (MSTX) And Acorda Therapeutics Inc (ACOR) at Insider Monkey
08:53AM  Acorda Stops Post-Stroke Development Program on Ampyra
08:00AM  What Trump isn't saying about drugmakers matters to investors at CNBC
07:00AM  Acorda Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-21-16 06:34PM  In Case You Missed It Monday: Markets Punch Through Record Highs
04:43PM  Dow, S&P, Nasdaq Close At Record Highs; Oil Surges 4% at Barrons.com
04:19PM  Acorda Scrapping Stroke Drug Just 'Small Disappointment': RBC
11:39AM  Why Acorda Therapeutics Stock Is Slumping Today at Motley Fool
11:36AM  Acorda Therapeutics: Punished By A "Small Disappointment" at Barrons.com
10:04AM  Acorda Slides on Clinical Study Update
09:25AM  Acorda Therapeutics plummets as much as 13% on failed trial, discontinued drug development at MarketWatch
09:17AM  Stocks to Watch: LifeLock, Tyson Foods, Headwaters at The Wall Street Journal
09:08AM  Acorda Stroke Study Fails, Dampening Revenue Growth Plans
08:58AM  Acorda Therapeutics sinks 13% on discontinuation of drug for post-stroke walking at MarketWatch
06:50AM  ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:00AM  Acorda to Discontinue Development of Dalfampridine for Treatment of Post-Stroke Walking Difficulties Business Wire
Nov-20-16 01:25PM  5 Trade Ideas for Monday: Acorda Therapeutics, Aflac, BlackRock, Cirrus Logic and Foot Locker
Nov-17-16 01:04PM  ACORDA THERAPEUTICS INC Financials
Nov-16-16 11:32AM  ETFs with exposure to Acorda Therapeutics, Inc. : November 16, 2016
Nov-15-16 07:35AM  Acorda Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ACOR-US : November 15, 2016
Nov-09-16 07:00AM  Acorda Therapeutics to Present at the Stifel 2016 Healthcare Conference Business Wire +10.83%
Nov-07-16 05:37PM  ACORDA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report +5.33%
03:30PM  Gurus' 6 Worst-Performing Stocks
Nov-06-16 11:52PM  3 Best Biotech Stocks of the 21st Century (So Far) at Motley Fool
Oct-28-16 08:25AM  Acorda (ACOR) Reports Wider Q3 Loss, Revenues Down Y/Y
Oct-27-16 02:36PM  Edited Transcript of ACOR earnings conference call or presentation 27-Oct-16 12:30pm GMT -7.59%
01:16PM  ETFs with exposure to Acorda Therapeutics, Inc. : October 27, 2016
08:30AM  Acorda Therapeutics Inc Earnings Call scheduled for 8:30 am ET today
07:07AM  Q3 2016 Acorda Therapeutics Inc Earnings Release - Before Market Open
06:44AM  ACORDA THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
06:32AM  Acorda reports 3Q loss
06:00AM  Acorda Provides Financial and Pipeline Update for Third Quarter 2016 Business Wire
Oct-17-16 07:00AM  Acorda to Host Conference Call to Discuss Third Quarter 2016 on October 27, 2016 Business Wire
Oct-13-16 07:31AM  ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +5.16%
07:00AM  Data from Clinical and Preclinical Trials of CVT-301 for Treatment of OFF Periods in Parkinsons Disease Published in Science Translational Medicine Business Wire
Oct-12-16 07:00AM  Acorda Named One of the Best Workplaces by Fortune Magazine and Great Place to Work Business Wire
Oct-05-16 07:01AM  ACORDA THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
Oct-04-16 06:00AM  Acorda Announces Departure of Michael Rogers Business Wire
Sep-30-16 07:16AM  ACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST GlobeNewswire
Sep-27-16 08:32AM  Acorda Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ACOR-US : September 27, 2016
Sep-26-16 04:04PM  Deutsche Bank, Kroger Slip into Mondays 52-Week Low Club at 24/7 Wall St. -15.73%
Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Zanaflex Capsules and tablets for the management of spasticity; and Qutenza, a dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops CVT-301 that is in the Phase IIb clinical trial for the treatment of OFF periods in Parkinson's disease; CVT-427, which has completed a Phase I clinical trial to treat migraine; and Ampyra/Dalfampridine that is in the Phase I pharmacokinetic studies for the treatment of chronic post-stroke deficits. Further, it develops Plumiaz, a proprietary nasal spray formulation of diazepam to treat people with epilepsy; Cimaglermin alfa/Neuregulins that has completed a Phase I clinical trial for the treatment of heart failure; Remyelinating Antibodies Program, which is in Phase I clinical trial for the treatment of MS; and Chondroitinase Program that is in research stage for the treatment of spinal cord injury. The company has collaborations and license agreements with Biogen International GmbH; Alkermes plc; Rush-Presbyterian St. Luke's Medical Center; Alkermes, Inc.; SK Biopharmaceuticals Co., Ltd.; Astellas Pharma Europe Ltd.; Canadian Spinal Research Organization; Cambridge Enterprise Limited and King's College London; Mayo Foundation for Education and Research; Paion AG; and Brigham and Women's Hospital, Inc. Acorda Therapeutics, Inc. was founded in 1995 and is headquartered in Ardsley, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blight AndrewChief Scientific OfficerFeb 09Option Exercise22.1367,5861,495,678144,144Feb 13 04:13 PM
Greene Barry EDirectorFeb 09Option Exercise22.1372316,000723Feb 13 04:14 PM
LAWRENCE DAVIDChief, Bus. Ops & PAOFeb 09Option Exercise22.1363,1831,398,24067,719Feb 13 04:15 PM
Wasman JanePresident, Intl and GCFeb 09Option Exercise22.1354,5361,206,882156,210Feb 13 04:16 PM
Wasman JanePresident, Intl and GCFeb 09Sale22.3054,5361,216,218101,674Feb 13 04:16 PM
LAWRENCE DAVIDChief, Bus. Ops & PAOFeb 09Sale22.3263,1831,410,5424,536Feb 13 04:15 PM
Greene Barry EDirectorFeb 09Sale22.6572316,3760Feb 13 04:14 PM
Blight AndrewChief Scientific OfficerFeb 09Sale22.4167,5861,514,37976,558Feb 13 04:13 PM
Greene Barry EDirectorJan 03Option Exercise15.913,01748,0003,017Jan 05 04:12 PM
Greene Barry EDirectorJan 03Sale19.263,01758,1130Jan 05 04:12 PM
COHEN RONPresident and CEODec 14Option Exercise15.4940,172622,264519,860Dec 16 08:08 AM
COHEN RONPresident and CEODec 14Sale20.7540,172833,655479,688Dec 16 08:08 AM
Blight AndrewChief Scientific OfficerDec 01Sale20.764,855100,77476,558Dec 05 05:03 PM
Wasman JanePresident, Intl and GCDec 01Sale20.743,34769,400101,674Dec 05 05:15 PM
Sabella Lauren MChief Commercial OfficerDec 01Sale20.742,42950,38111,949Dec 05 05:14 PM
LAWRENCE DAVIDChief, Bus. Ops & PAODec 01Sale20.744,41691,5944,536Dec 05 05:11 PM
Hindman Andrew A.Chief Business Dev. OfficerDec 01Sale20.724439,18049,227Dec 05 05:09 PM
COHEN RONPresident and CEODec 01Sale20.747,160148,482479,688Dec 05 05:08 PM
BLANK BURKHARDChief Medical OfficerDec 01Sale20.7410,000207,44240,000Dec 05 05:06 PM
Batycky Richard P.Chief Tech. Off. & Site HeadOct 21Sale20.302,06341,87745,916Oct 25 07:06 AM
LAWRENCE DAVIDChief, Bus. Ops & PAOOct 07Sale20.822505,2058,952Oct 11 07:31 AM
Wasman JanePresident, Intl and GCOct 03Sale20.783,75077,927105,021Oct 05 04:18 PM
Wasman JanePresident, Intl and GCSep 23Option Exercise8.505004,250109,271Sep 27 08:01 AM
Wasman JanePresident, Intl and GCSep 23Sale27.3250013,660108,771Sep 27 08:01 AM
Blight AndrewChief Scientific OfficerAug 09Option Exercise22.139,754215,85681,413Aug 11 03:54 PM
LAWRENCE DAVIDChief of Business OperationsJun 22Option Exercise8.505004,2509,702Jun 24 07:34 AM
LAWRENCE DAVIDChief of Business OperationsJun 22Sale25.0950012,5459,202Jun 24 07:34 AM
Wasman JanePresident, Intl and GCJun 10Option Exercise22.138,647191,358108,771Jun 14 08:42 AM
RAUSCHER STEVEN MDirectorJun 08Option Exercise18.651,08620,2541,086Jun 10 07:25 AM
RAUSCHER STEVEN MDirectorJun 08Sale27.831,08630,2240Jun 10 07:25 AM
Hindman Andrew A.Chief Business Dev. OfficerMay 13Sale26.114,860126,88549,670May 16 03:12 PM
Randall LorinDirectorApr 19Option Exercise18.651,48827,7511,488Apr 21 07:57 AM
Randall LorinDirectorApr 19Sale28.681,48842,6760Apr 21 07:57 AM